American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
about
Getting Past No in Cancer Care.State insurance mandates and off-label use of chemotherapy.Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs.Topographies of 'care pathways' and 'healthscapes': Reconsidering the multiple journeys of people with a brain tumour.Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons.
P2860
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
@en
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
@nl
type
label
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
@en
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
@nl
prefLabel
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
@en
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
@nl
P2093
P356
P1476
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
@en
P2093
Dana S Wollins
James N Frame
Linda D Bosserman
Michael N Neuss
Ray D Page
Robin T Zon
Steven Stranne
P304
P356
10.1200/JOP.2015.009134
P407
P577
2016-01-12T00:00:00Z